×
ADVERTISEMENT

neutropenia

Continuous Temperature Monitoring Could Detect Febrile Neutropenia

Remote temperature monitoring devices may enable early detection of febrile neutropenia in adults with AML who have ...

MAY 21, 2024

Study Finds Little Difference in Same-Day Versus Next-Day Pegfilgrastim in Breast Cancer

A retrospective analysis of breast cancer patients found no significant difference in neutropenia-related events ...

DECEMBER 4, 2023

Resistance Concerns Cloud Neutropenia Prophylaxis Recs

With concerns of resistance and increased potential for poor outcomes, the benefit of fluoroquinolone prophylaxis ...

FEBRUARY 7, 2023

FDA Approves Stimufend, Biosimilar for Neulasta

The FDA approved Stimufend, a biosimar for Neulasta, for patients with non-myeloid malignancies receiving ...

SEPTEMBER 7, 2022

Neutropenic Fever Declines Amid COVID-19

Orlando, Fla.—During the height of the COVID-19 pandemic, the seven hospitals affiliated with the University ...

JULY 26, 2022

COVID-19 Precautions Associated With Decline in Neutropenic Fever Among Cancer Patients

Orlando, Fla.—A series of pandemic-related public health measures such as the use of barrier masks, ...

JUNE 2, 2022

Better Risk Modeling for Febrile Neutropenia

Nearly 120,000 adults and children are hospitalized annually with neutropenia caused by cancer chemotherapy, at a ...

MARCH 11, 2019

FDA Approves Nivestym, Second Biosimilar of Neupogen

The FDA approved Pfizer's Nivestym, a biosimilar of Neupogen for all eligible indications as the reference ...

JULY 23, 2018

Reducing Infection Risk in Young Leukemia Patients

The first few weeks is a crucial stage in monitoring and preventing infection in these children.

SEPTEMBER 14, 2017

Quinolones Reduce Infections, Delay Febrile Neutropenia in Relapsed/Refractory AML Patients

Treating patients with relapsed/refractory AML prophylactically with quinolones reduced the incidence of bacteremia ...

JULY 5, 2016

Load more